November 16th 2024
CHMP has granted Eisai Europe and Biogen a positive opinion for the use of their monoclonal antibody therapy in treating early Alzheimer’s disease.
Formulation and Functional Considerations for Delivering Biologics in Prefilled Syringes
January 8th 2018Graham Reynolds, vice-president and general manager, Global Biologics at West Pharmaceutical Services, Inc., shares insights on key considerations when developing a biologic drug product in a prefilled syringe.
Federal Circuit Decides in Favor of Novartis in Biosimilars Patent Dispute with Amgen
December 18th 2017The US Court of Appeals for the Federal Circuit has decided in favor of Novartis’ Sandoz in rendering the opinion that Amgen cannot use state laws to prohibit or delay the marketing of biosimilars.